Prostate cancer progression defined by MRI correlates with serum PSA in men undergoing lifestyle and nutritional interventions for low risk disease

R. Thomas; M. Shaikh; M. Cauchi; D.D. Yang

Prostate cancer progression defined by MRI correlates with serum PSA in men undergoing lifestyle and nutritional interventions for low risk disease

R. Thomas, M. Shaikh, M. Cauchi, D.D. Yang

Research output: Contribution to journal › Article

4 Downloads (Pure)

Abstract

Background: Men with low-risk prostate cancer are often offered active surveillance (AS), sparing them the toxicities of radical therapies and providing them with the opportunity to embark on healthy lifestyle and nutritional strategies. Annual magnetic resonance imaging (MRI) is increasingly being used to help monitor disease progress although its precise role has not been fully established. Hitherto no study has correlated changes in MRI disease status with Prostate Specific Antigen (PSA) dynamics among men managed with AS. Methods: We correlated 346 serum PSA levels with 346 MRIs of 138 men who had at least two prostate MRI scans, and who had prostate cancer managed with AS. All men were given lifestyle information guidance and 102 were also were also taking, long term, a polyphenol rich food supplement following initial recruitment in the UK’s Pomi-t study. Results: Men with progression seen on MRI had a mean 39.78% rise in PSA (confident interval (CI) 28 to 52%), compared to those whose disease shrunk (-16.05%, CI 14 to -46%), remained stable (1.62% CI -3 to 5%), or was not visualised (-1.62%, CI -14 to 11%) (ANOVA, P-value

Original language	English
Pages (from-to)	1-8
Journal	Journal of Lifestyle Diseases and Management
Volume	1
Issue number	15
Publication status	Published - 2015
Externally published	Yes

Bibliographical note

This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.

Keywords

Active surveillance
Multiparametric MRI
Prostate cancer
PSA

Access to Document

Published versionFinal published version, 424 KB

http://sciencescript.org/jldm/archives/article/prostate-cancer-progression-defined-mri-correlates-serum-psa-men-undergoing-lifestyle-nutritional-interventions-low-risk-disease

Fingerprint Dive into the research topics of 'Prostate cancer progression defined by MRI correlates with serum PSA in men undergoing lifestyle and nutritional interventions for low risk disease'. Together they form a unique fingerprint.

Cite this

Thomas, R., Shaikh, M., Cauchi, M., & Yang, D. D. (2015). Prostate cancer progression defined by MRI correlates with serum PSA in men undergoing lifestyle and nutritional interventions for low risk disease. Journal of Lifestyle Diseases and Management, 1(15), 1-8.

@article{955d687c20b540b0b88bbf3c273321c0,

title = "Prostate cancer progression defined by MRI correlates with serum PSA in men undergoing lifestyle and nutritional interventions for low risk disease",

abstract = "Background: Men with low-risk prostate cancer are often offered active surveillance (AS), sparing them the toxicities of radical therapies and providing them with the opportunity to embark on healthy lifestyle and nutritional strategies. Annual magnetic resonance imaging (MRI) is increasingly being used to help monitor disease progress although its precise role has not been fully established. Hitherto no study has correlated changes in MRI disease status with Prostate Specific Antigen (PSA) dynamics among men managed with AS. Methods: We correlated 346 serum PSA levels with 346 MRIs of 138 men who had at least two prostate MRI scans, and who had prostate cancer managed with AS. All men were given lifestyle information guidance and 102 were also were also taking, long term, a polyphenol rich food supplement following initial recruitment in the UK’s Pomi-t study. Results: Men with progression seen on MRI had a mean 39.78{\%} rise in PSA (confident interval (CI) 28 to 52{\%}), compared to those whose disease shrunk (-16.05{\%}, CI 14 to -46{\%}), remained stable (1.62{\%} CI -3 to 5{\%}), or was not visualised (-1.62{\%}, CI -14 to 11{\%}) (ANOVA, P-value",

keywords = "Active surveillance, Multiparametric MRI, Prostate cancer, PSA",

author = "R. Thomas and M. Shaikh and M. Cauchi and D.D. Yang",

note = "This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.",

year = "2015",

language = "English",

volume = "1",

pages = "1--8",

journal = "Journal of Lifestyle Diseases and Management",

publisher = "ScienceScript",

number = "15",

}

TY - JOUR

T1 - Prostate cancer progression defined by MRI correlates with serum PSA in men undergoing lifestyle and nutritional interventions for low risk disease

AU - Thomas, R.

AU - Shaikh, M.

AU - Cauchi, M.

AU - Yang, D.D.

N1 - This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.

PY - 2015

Y1 - 2015

N2 - Background: Men with low-risk prostate cancer are often offered active surveillance (AS), sparing them the toxicities of radical therapies and providing them with the opportunity to embark on healthy lifestyle and nutritional strategies. Annual magnetic resonance imaging (MRI) is increasingly being used to help monitor disease progress although its precise role has not been fully established. Hitherto no study has correlated changes in MRI disease status with Prostate Specific Antigen (PSA) dynamics among men managed with AS. Methods: We correlated 346 serum PSA levels with 346 MRIs of 138 men who had at least two prostate MRI scans, and who had prostate cancer managed with AS. All men were given lifestyle information guidance and 102 were also were also taking, long term, a polyphenol rich food supplement following initial recruitment in the UK’s Pomi-t study. Results: Men with progression seen on MRI had a mean 39.78% rise in PSA (confident interval (CI) 28 to 52%), compared to those whose disease shrunk (-16.05%, CI 14 to -46%), remained stable (1.62% CI -3 to 5%), or was not visualised (-1.62%, CI -14 to 11%) (ANOVA, P-value

AB - Background: Men with low-risk prostate cancer are often offered active surveillance (AS), sparing them the toxicities of radical therapies and providing them with the opportunity to embark on healthy lifestyle and nutritional strategies. Annual magnetic resonance imaging (MRI) is increasingly being used to help monitor disease progress although its precise role has not been fully established. Hitherto no study has correlated changes in MRI disease status with Prostate Specific Antigen (PSA) dynamics among men managed with AS. Methods: We correlated 346 serum PSA levels with 346 MRIs of 138 men who had at least two prostate MRI scans, and who had prostate cancer managed with AS. All men were given lifestyle information guidance and 102 were also were also taking, long term, a polyphenol rich food supplement following initial recruitment in the UK’s Pomi-t study. Results: Men with progression seen on MRI had a mean 39.78% rise in PSA (confident interval (CI) 28 to 52%), compared to those whose disease shrunk (-16.05%, CI 14 to -46%), remained stable (1.62% CI -3 to 5%), or was not visualised (-1.62%, CI -14 to 11%) (ANOVA, P-value

KW - Active surveillance

KW - Multiparametric MRI

KW - Prostate cancer

KW - PSA

M3 - Article

VL - 1

SP - 1

EP - 8

JO - Journal of Lifestyle Diseases and Management

JF - Journal of Lifestyle Diseases and Management

IS - 15

ER -